NASDAQ:MDVN - Medivation Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$81.44 0.00 (0.00 %)
(As of 06/20/2018 04:00 PM ET)
Previous Close$81.44
Today's Range$81.44 - $81.44
52-Week Range$26.41 - $81.48
VolumeN/A
Average Volume3.55 million shs
Market Capitalization$13.52 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.6
Medivation logoMedivation, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of therapies to treat serious diseases for which there are limited treatment options. The Company, in collaboration with Astellas Pharma, Inc. (Astellas), has one commercial product, XTANDI (enzalutamide) capsules (XTANDI). XTANDI has received marketing approval in the United States, Europe and other countries across the world for the treatment of patients with metastatic castration-resistant prostate cancer (mCRPC) and in Japan for the treatment of patients with castration-resistant prostate cancer (CRPC). The Company, in collaboration with Astellas, is also conducting investigational studies of enzalutamide in prostate cancer and in advanced breast cancer. It has developed a small molecule inhibitor of the sterol regulatory element-binding protein, or SREBP, pathway which it refers to as MDV4463.

Receive MDVN News and Ratings via Email

Sign-up to receive the latest news and ratings for MDVN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryBiotechnology
SectorN/A
SymbolNASDAQ:MDVN
CUSIP58501N10
Phone+1-415-5433470

Debt

Debt-to-Equity Ratio0.03
Current Ratio4.32
Quick Ratio4.32

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-195.92%
Return on Equity-225.98%
Return on Assets-108.55%

Miscellaneous

Employees628
Outstanding Shares165,010,000

Medivation (NASDAQ:MDVN) Frequently Asked Questions

What is Medivation's stock symbol?

Medivation trades on the NASDAQ under the ticker symbol "MDVN."

How were Medivation's earnings last quarter?

Medivation Inc (NASDAQ:MDVN) released its quarterly earnings data on Tuesday, August, 9th. The biopharmaceutical company reported $0.29 earnings per share for the quarter, topping analysts' consensus estimates of $0.27 by $0.02. The biopharmaceutical company earned $206 million during the quarter, compared to analyst estimates of $214.52 million. Medivation had a negative return on equity of 225.98% and a negative net margin of 195.92%. The business's quarterly revenue was up 17.4% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.58 earnings per share. View Medivation's Earnings History.

Has Medivation been receiving favorable news coverage?

News coverage about MDVN stock has been trending positive recently, Accern Sentiment reports. The research group identifies positive and negative press coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Medivation earned a daily sentiment score of 0.43 on Accern's scale. They also assigned press coverage about the biopharmaceutical company an impact score of 48.26 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company's share price in the near term.

How do I buy shares of Medivation?

Shares of MDVN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Medivation's stock price today?

One share of MDVN stock can currently be purchased for approximately $81.44.

How big of a company is Medivation?

Medivation has a market capitalization of $13.52 billion. Medivation employs 628 workers across the globe.

How can I contact Medivation?

Medivation's mailing address is 525 Market St Fl 36, SAN FRANCISCO, CA 94105-2747, United States. The biopharmaceutical company can be reached via phone at +1-415-5433470.


MarketBeat Community Rating for Medivation (MDVN)

Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  636 (Vote Outperform)
Underperform Votes:  389 (Vote Underperform)
Total Votes:  1,025
MarketBeat's community ratings are surveys of what our community members think about Medivation and other stocks. Vote "Outperform" if you believe MDVN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MDVN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.